Brief: Infant Bacterial Therapeutics Q2 Operating Loss Of SEK 20.1 Mln
20/08/2025 07:15
Aug 20 (Reuters) - Infant Bacterial Therapeutics AB IBTb.ST: Q2 OPERATING LOSS OF -20,126 TSEK Source text: ID:nMFN9WJfXS Further company coverage: [IBTb.ST] (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Infant Bacterial Therapeutics AB
See all newsBrief: Infant Bacterial Therapeutics Gets FDA Request For Type B Pre-BLA Meeting
Brief: Infant Bacterial Therapeutics Q2 Operating Loss Widens To SEK 30.1 Mln
Brief: Infant Bacterial Therapeutics CFO Leaves The Company
Brief: Infant Bacterial Announces Phase III IBP-9414 Study Results
Brief: Infant Bacterial Therapeutics Q4 Operating Loss SEK 20.5 Mln